Wellington Partners leads NEUWAY Series A

Wellington Partners has led a series A financing round at German-based NEUWAY Pharma GmbH. The business is the first spin-off from Life Science Inkubator in Bonn. NEUWAY is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases.

North AmericaUSBriefs